pyruvic acid has been researched along with Argininosuccinate Synthase Deficiency Disease in 7 studies
Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saheki, T | 6 |
| Moriyama, M | 2 |
| Kuroda, E | 2 |
| Funahashi, A | 1 |
| Yasuda, I | 1 |
| Setogawa, Y | 1 |
| Gao, Q | 1 |
| Ushikai, M | 2 |
| Furuie, S | 2 |
| Yamamura, KI | 1 |
| Takano, K | 1 |
| Nakamura, Y | 2 |
| Eto, K | 2 |
| Kadowaki, T | 2 |
| Sinasac, DS | 3 |
| Furukawa, T | 1 |
| Horiuchi, M | 2 |
| Tai, YH | 1 |
| Mutoh, K | 1 |
| Kurokawa, K | 1 |
| Kobayashi, K | 4 |
| Yazaki, M | 2 |
| Ikeda, S | 2 |
| Inoue, K | 1 |
| Ono, H | 1 |
| Katsura, N | 1 |
| Yokogawa, M | 1 |
| Yoshidumi, Y | 1 |
| Asakawa, A | 1 |
| Inui, A | 1 |
| Yamamura, K | 1 |
| Kinoshita, M | 1 |
| Ogawa, S | 1 |
| Fujimi, S | 1 |
| Matsushima, A | 1 |
| Hineno, A | 1 |
| Tazawa, K | 1 |
| Fukushima, K | 1 |
| Kimura, R | 1 |
| Yanagida, M | 1 |
| Matsunaga, H | 1 |
| Li, MX | 1 |
| Kannan, Y | 1 |
| Iijima, M | 1 |
| Tsui, LC | 1 |
| Tanaka, M | 1 |
| Larovere, L | 1 |
| Latini, A | 1 |
| Depetris-Boldini, C | 1 |
| Coronel, CE | 1 |
| de Kremer, RD | 1 |
7 other studies available for pyruvic acid and Argininosuccinate Synthase Deficiency Disease
| Article | Year |
|---|---|
Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model.
Topics: Amino Acids; Ammonia; Ammonium Chloride; Animals; Aspartic Acid; Citrulline; Citrullinemia; Disease | 2019 |
Treatment of a citrin-deficient patient at the early stage of adult-onset type II citrullinaemia with arginine and sodium pyruvate.
Topics: Administration, Oral; Adolescent; Arginine; Biomarkers; Citrullinemia; Diet, Carbohydrate-Restricted | 2008 |
[Therapeutic approaches for patients with adult-onset type II citrullinemia (CTLN2): effectiveness of treatment with low-carbohydrate diet and sodium pyruvate].
Topics: Administration, Oral; Adolescent; Adult; Aged; Calcium-Binding Proteins; Child; Citrullinemia; Diet, | 2010 |
Effects of supplementation on food intake, body weight and hepatic metabolites in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse model of human citrin deficiency.
Topics: Alanine; Animals; Body Weight; Cholestasis, Intrahepatic; Citrullinemia; Dietary Proteins; Disease M | 2012 |
A 73-year-old patient with adult-onset type II citrullinemia successfully treated by sodium pyruvate and arginine.
Topics: Aged; Ammonia; Arginine; Blood Chemical Analysis; Citrullinemia; Consciousness Disorders; Female; Hu | 2013 |
Pyruvate ameliorates the defect in ureogenesis from ammonia in citrin-deficient mice.
Topics: Amino Acids; Ammonia; Animals; Anticoagulants; Aspartic Acid; Calcium-Binding Proteins; Citric Acid; | 2006 |
Cerebrospinal fluid purines, pyrimidines, organic acids and amino acids in neonatal citrullinaemia.
Topics: 3-Hydroxybutyric Acid; Amino Acids; Child; Child, Preschool; Citrullinemia; Humans; Infant; Infant, | 2000 |